RyR2 has almost 5,000 amino acid residues, which, in combination with the rarity of CPVT, means that many patients are found to carry novel missense variants, appropriately classified as VUSs. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.